HOME >> MEDICINE >> NEWS
Work on cancer-killing compound nets FSU professor major grant

TALLAHASSEE, Fla.--Within a laboratory on the Florida State University campus, a chemist leads a team of researchers in a quest to develop synthetic versions of rare natural substances. If all goes well, the team's efforts could pay off in the form of the next generation of cancer-fighting drugs.

Such research often is a long, laborious process that can take years to generate results -- but is essential if breakthroughs in medicine, engineering and the sciences are to occur. In the FSU chemist's case, the state of Florida has acknowledged that the wait may well be worth it.

Gregory B. Dudley, an assistant professor in FSU's department of chemistry and biochemistry, recently was awarded a $450,000, three-year grant from the James & Esther King Biomedical Research Program, which is operated by the Florida Department of Health.

The program (www.floridabiomed.com) supports biomedical research on the prevention, diagnosis, treatments and cures for tobacco-related diseases, including cancer.

Dudley and his doctoral students are doing research on the synthesis of roseophilin, a naturally occurring compound produced by an obscure species of bacteria. Roseophilin (pronounced rose-ee-oh-FILL-in), which was first identified by Japanese researchers in 1992, is cytotoxic, meaning it kills cancer cells.

Public funding such as the King grant is essential if scientists are to continue to make progress in the ongoing battle against cancer and other diseases, Dudley said.

"The grant will allow us to engage in the kind of fundamental research that is needed to bring down the cost and increase the effectiveness of future pharmaceutical drugs," he said.

Dudley explained that the overall mission of his lab is to develop better access to synthetic versions of "biologically important" chemicals for which nature provides a limited supply. Typically, he said, he and his students choose a molecule that has shown interesting properties and
'"/>

Contact: Gregory B. Dudley
gdudley@chem.fsu.edu
850-644-2333
Florida State University
12-Oct-2005


Page: 1 2 3

Related medicine news :

1. Nanoparticles carry cancer-killing drugs into tumor cells
2. New oxidation methods streamline synthesis of important compounds
3. AMPAKINE compounds a new potential treatment for respiratory depression
4. Green tea compound suppresses factors causing cartilage, bone destruction in arthritis
5. Green tea compound may be a therapy for people with rheumatoid arthritis
6. Anti-dandruff compound may help fight epilepsy
7. Depression among retired NFL players: Rates mirror the general public, but pain compounds symptoms
8. Chromium 6: A killer compound with an improbable trigger
9. New compound shows promise in halting HIV spread
10. New imaging compound might see Alzheimers earlier
11. U of M researchers discover compounds to shrink tumors

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare events ... Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the ... The annual award competition recognizes editorial and design excellence across a range of sectors. ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the ... – Miles by Moonlight to raise money for the American Heart Association Heart Walk. ... , Teams will work together to keep their treadmills moving for 5 hours. Treadmills ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations (HLI), ... software tool, and the Cancer Patient Education Network (CPEN), an independent professional organization ... a new strategic alliance. , As CPEN’s strategic partner, HLI will help ...
(Date:10/12/2017)... ... 2017 , ... Vohra Chief Medical Officer Dr. Shark Bird, ... nursing facility medical directors and other clinicians at various events in October. His ... many of these conferences we get to educate other physicians, facility nurses, corporate ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Fla. , Oct. 2, 2017  AllianceRx Walgreens ... company formed by Walgreens and pharmacy benefit manager Prime ... its new brand, which included the unveiling of new ... , as well as at a few other ... the new brand to patients, some of whom will ...
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile app ... struggle to reverse the tide of prescription drug addiction. The ... their medicine intake and stepping down their dosage in a ... launch in December 2017; the first 100,000 people to sign ... at http://www.rebound-solution.com/ ...
(Date:9/28/2017)... Sept. 28, 2017 Cohen Veterans Bioscience and ... use of wearable and home sensors for real-time monitoring ... Signal Foundation, a nonprofit organization focused on disruptive health ... an affordable analytical system to record and integrate behavioral, ... ...
Breaking Medicine Technology:
Cached News: